| Breakdown | TTM | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 86.15B | 83.97B | 85.43B | 78.21B | 71.83B | 52.43B |
| Gross Profit | 37.17B | 33.67B | 34.02B | 29.61B | 23.01B | 17.14B |
| EBITDA | 7.75B | 6.41B | 8.20B | 4.37B | 1.61B | 214.00M |
| Net Income | 930.00M | -665.00M | 3.02B | 5.48B | -1.76B | -11.41B |
Balance Sheet | ||||||
| Total Assets | 213.52B | 208.90B | 211.14B | 178.80B | 188.78B | 191.21B |
| Cash, Cash Equivalents and Short-Term Investments | 14.55B | 14.91B | 20.79B | 16.11B | 16.79B | 18.31B |
| Total Debt | 66.73B | 71.21B | 71.27B | 58.28B | 73.22B | 78.25B |
| Total Liabilities | 117.58B | 115.74B | 116.67B | 92.32B | 107.94B | 110.59B |
| Stockholders Equity | 95.85B | 93.06B | 94.37B | 86.39B | 80.03B | 80.18B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.40B | -7.34B | 5.20B | 2.54B | -10.26B |
| Operating Cash Flow | 0.00 | -586.00M | 8.13B | 6.06B | 4.81B | -8.14B |
| Investing Cash Flow | 0.00 | -3.66B | -15.24B | 11.51B | -868.00M | -3.11B |
| Financing Cash Flow | 0.00 | -1.53B | 11.78B | -15.31B | -5.78B | 8.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥407.48B | 15.93 | ― | 0.33% | 6.38% | 38.69% | |
69 Neutral | ¥1.39T | 28.41 | 11.19% | 1.12% | 10.99% | 2.35% | |
66 Neutral | ¥522.46B | 28.18 | ― | 1.12% | 5.90% | 17.39% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | ¥25.58B | 124.21 | ― | 1.11% | -4.66% | -56.66% | |
49 Neutral | ¥53.37B | 6.12 | 4.10% | 4.16% | 11.52% | 162.04% | |
46 Neutral | ¥156.56B | 52.66 | ― | 0.26% | 14.49% | ― |
Shochiku has revised upward its consolidated full-year earnings forecast for the fiscal year ending February 2026, keeping net sales unchanged at ¥97 billion but lifting operating profit by 27.9% to ¥5.5 billion, ordinary profit to ¥5.7 billion, and profit attributable to owners of parent to ¥5.0 billion, reflecting robust box office performance in its motion picture operations and continued strength at the Kabukiza-led theatre business. On a non-consolidated basis, the company now expects slightly lower net sales of ¥55.1 billion but higher profits, with ordinary profit and net profit forecast to rise to ¥3.5 billion and ¥3.2 billion, respectively, driven by strong theatre demand and high-margin broadcasting rights sales, marking a sharp turnaround from last year’s losses and underscoring an improving earnings structure across its core entertainment segments.
The most recent analyst rating on (JP:9601) stock is a Hold with a Yen12632.00 price target. To see the full list of analyst forecasts on Shochiku Co., Ltd. stock, see the JP:9601 Stock Forecast page.
Shochiku reported a sharp turnaround in performance for the nine months ended November 30, 2025, with consolidated net sales rising 25.8% year on year to ¥74.8 billion and profit attributable to owners of parent swinging from a loss of ¥1.0 billion a year earlier to a profit of ¥5.0 billion. Operating profit surged to ¥5.5 billion from virtually breakeven, and the equity-to-asset ratio improved to 46.8%, reflecting stronger profitability and a healthier balance sheet; basic earnings per share rose to ¥361.20 from a loss per share in the previous period. The company maintained its annual dividend forecast of ¥30 per share for the fiscal year ending February 28, 2026, and revised its full-year earnings outlook, now projecting ¥97.0 billion in net sales and ¥5.0 billion in profit attributable to owners of parent, signaling confidence in sustained recovery and improved earnings power after prior-year weakness.
The most recent analyst rating on (JP:9601) stock is a Hold with a Yen12632.00 price target. To see the full list of analyst forecasts on Shochiku Co., Ltd. stock, see the JP:9601 Stock Forecast page.